These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 21756932)
21. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice. Xiong WT; Gu L; Wang C; Sun HX; Liu X J Ethnopharmacol; 2013 Dec; 150(3):935-45. PubMed ID: 24095831 [TBL] [Abstract][Full Text] [Related]
22. Effects of the novel oral antidiabetic agent HQL-975 on glucose and lipid metabolism in diabetic db/db mice. Ishikawa Y; Watanabe K; Takeno H; Tani T Arzneimittelforschung; 1998 Mar; 48(3):245-50. PubMed ID: 9553681 [TBL] [Abstract][Full Text] [Related]
23. Protective Effects of MDG-1, a Polysaccharide from Ophiopogon japonicus on Diabetic Nephropathy in Diabetic KKAy Mice. Wang Y; Shi LL; Wang LY; Xu JW; Feng Y Int J Mol Sci; 2015 Sep; 16(9):22473-84. PubMed ID: 26393572 [TBL] [Abstract][Full Text] [Related]
24. Hypoglycemic, hypolipidemic and antioxidant effects of Sarcandra glabra polysaccharide in type 2 diabetic mice. Liu W; Zheng Y; Zhang Z; Yao W; Gao X Food Funct; 2014 Nov; 5(11):2850-60. PubMed ID: 25254968 [TBL] [Abstract][Full Text] [Related]
25. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model. Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226 [TBL] [Abstract][Full Text] [Related]
26. Studies on antidiabetic effects of cortex Moutan polysaccharide-2b in type 2 diabetes mellitus rats. Hong H; Wang QM; Zhao ZP; Liu GQ; Shen YS; Chen GL Yao Xue Xue Bao; 2003 Apr; 38(4):255-9. PubMed ID: 12889122 [TBL] [Abstract][Full Text] [Related]
27. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022 [TBL] [Abstract][Full Text] [Related]
28. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice. Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727 [TBL] [Abstract][Full Text] [Related]
29. Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. Hamza N; Berke B; Cheze C; Agli AN; Robinson P; Gin H; Moore N J Ethnopharmacol; 2010 Mar; 128(2):513-8. PubMed ID: 20064599 [TBL] [Abstract][Full Text] [Related]
30. Fraxinus excelsior seed extract FraxiPure™ limits weight gains and hyperglycemia in high-fat diet-induced obese mice. Ibarra A; Bai N; He K; Bily A; Cases J; Roller M; Sang S Phytomedicine; 2011 Apr; 18(6):479-85. PubMed ID: 21036576 [TBL] [Abstract][Full Text] [Related]
31. Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Nakagawa T; Goto H; Hussein G; Hikiami H; Shibahara N; Shimada Y Diabetes Res Clin Pract; 2008 Apr; 80(1):40-7. PubMed ID: 18242756 [TBL] [Abstract][Full Text] [Related]
32. [Effects of Panax notoginseng saponins on anti-hyperglycemic, anti-obese and prevention from kidney pathological changes in KK-Ay mice]. Yang CY; Xie ZG; Cheng WB; Jiang X; Chen ZH Zhong Yao Cai; 2009 Oct; 32(10):1571-6. PubMed ID: 20112724 [TBL] [Abstract][Full Text] [Related]
33. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model. Lim S; Yoon JW; Choi SH; Cho BJ; Kim JT; Chang HS; Park HS; Park KS; Lee HK; Kim YB; Jang HC Metabolism; 2009 Jan; 58(1):8-15. PubMed ID: 19059525 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide. Irwin N; Clarke GC; Green BD; Greer B; Harriott P; Gault VA; O'Harte FP; Flatt PR Biochem Pharmacol; 2006 Sep; 72(6):719-28. PubMed ID: 16859646 [TBL] [Abstract][Full Text] [Related]
36. Antidiabetic potential of phycocyanin: effects on KKAy mice. Ou Y; Lin L; Yang X; Pan Q; Cheng X Pharm Biol; 2013 May; 51(5):539-44. PubMed ID: 23368938 [TBL] [Abstract][Full Text] [Related]
37. Effect of RU486 on hepatic and adipocyte gene expression improves diabetes control in obesity-type 2 diabetes. Taylor AI; Frizzell N; McKillop AM; Flatt PR; Gault VA Horm Metab Res; 2009 Dec; 41(12):899-904. PubMed ID: 19670152 [TBL] [Abstract][Full Text] [Related]
38. Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice. O'Harte FP; Franklin ZJ; Irwin N Diabetes Obes Metab; 2014 Dec; 16(12):1214-22. PubMed ID: 25060150 [TBL] [Abstract][Full Text] [Related]
39. MDG-1, an Ophiopogon polysaccharide, alleviates hyperlipidemia in mice based on metabolic profile of bile acids. Shi L; Wang J; Wang Y; Feng Y Carbohydr Polym; 2016 Oct; 150():74-81. PubMed ID: 27312615 [TBL] [Abstract][Full Text] [Related]
40. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes. Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]